Cargando…
Clinical safety and tolerability issues in use of triazole derivatives in management of fungal infections
There has been an increase in the number of patients susceptible to invasive fungal infections (IFIs) leading to a greater need for effective, well tolerated, and easily administered antifungal agents. The advent of triazoles has revolutionized the care of patients requiring treatment or prophylaxis...
Autores principales: | Neofytos, Dionissios, Avdic, Edina, Magiorakos, Anna-Pelagia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108707/ https://www.ncbi.nlm.nih.gov/pubmed/21701616 |
Ejemplares similares
-
The rise of carbapenem resistance in Europe: just the tip of the iceberg?
por: Magiorakos, Anna-Pelagia, et al.
Publicado: (2013) -
Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs
por: Wang, J.-F., et al.
Publicado: (2014) -
Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections
por: Ostrosky-Zeichner, L., et al.
Publicado: (2022) -
Special Issue: Mucosal Fungal Infections
por: Richardson, Jonathan P., et al.
Publicado: (2018) -
Special Issue: Treatments for Fungal Infections
por: Segal, Esther, et al.
Publicado: (2018)